Revised diagnostic criteria of multiple sclerosis

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 518-524

  Milo, Ron ^a   Miller, Ariel ^b,c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

Author keywords

Diagnosis; Diagnostic criteria; Dissemination in space (DIS); Dissemination in time (DIT); McDonald criteria; Multiple sclerosis (MS)

Indexed keywords

HLA DRB1 ANTIGEN; IMMUNOGLOBULIN; OLIGOCLONAL BAND;

AUSTRALIA; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DYSPHAGIA; ENVIRONMENTAL FACTOR; EUROPE; EVOKED AUDITORY RESPONSE; GENETIC SUSCEPTIBILITY; HISTORY; HUMAN; LIMB WEAKNESS; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEOSIS; MULTIPLE SCLEROSIS; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; RADIATION EXPOSURE; REVIEW; SENSITIVITY AND SPECIFICITY; SEX RATIO; SMOKING; SODIUM INTAKE; SUNLIGHT; ULTRAVIOLET RADIATION; VISUAL DISORDER; VITAMIN D DEFICIENCY;

DIAGNOSIS; DIAGNOSTIC CRITERIA; DISSEMINATION IN SPACE (DIS); DISSEMINATION IN TIME (DIT); MCDONALD CRITERIA; MULTIPLE SCLEROSIS (MS);

DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PROGNOSIS; RECURRENCE;

EID: 84896318533     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.012     Document Type: Review

References (44)

1. Compston A., Lassmann H., McDonald I. The history of multiple sclerosis. McAlpine's multiple sclerosis 2006, 3-68. Churchill Livingstone/Elsevier, Philadelphia. A. Compston, C. Confavreux, H. Lassmann, I. McDonald, D. Miller, J. Noseworthy, K. Smith, H. Wekerle (Eds.).
2. Charcot J.M. Histologie de la sclerose en plaques. Gaz HopParis 1868, 41:554-555. 557-8, 566.
3. Charcot J.M. Ouevres complètes de J.-M. Charcot. Leçons sur les maladies du système nerveux recueilles et publiées par Bourneville 1886, Tome 1. Bureau du Progres Medical and A Delahaye, Paris.
4. Rivers T.M., Sprunt D.H., Berry G.P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 1933, 58:39-53.
5. Kabat E.A., Glusman M., Knaub V. Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods. Am J Med 1948, 4:653-662.
6. Milo R., Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010, 9:A387-A394.
7. Gale C.R., Martyn C.N. Migrant studies in multiple sclerosis. Prog Neurobiol 1995, 47:425-448.
8. Kurtzke J.F. Epidemiology in multiple sclerosis: a pilgrim's progress. Brain 2013, 136:2904-2917.
9. Wu C., Yosef N., Thalhamer T., Zhu C., Xiao S., Kishi Y., et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013, 496:513-517.
10. Kleinewietfeld M., Manzel A., Titze J., Kvakan H., Yosef N., Linker R.A., et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013, 496:518-522.
11. Hauser S.L., Chan J.R., Oksenberg J.R. Multiple sclerosis: prospects and promise. Ann Neurol 2013, 74:317-327.
12. Compston A., Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
13. O'Connor P. Canadian Multiple Sclerosis Working Group. Key issues in the diagnosis and treatment of multiple sclerosis: an overview. Neurology 2002, 59(6 Suppl. 3):S1-S33.
14. Kremenchutzky M., Rice G.P., Baskerville J., Wingerchuk D.M., Ebers G.C. The natural history of multiple sclerosis: a geographically based study 9-observations on the progressive phase of the disease. Brain 2006, 129:584-594.
15. Bergamaschi R. Prognostic factors in multiple sclerosis. Int Rev Neurobiol 2007, 79:423-447.
16. Lublin F.D., Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996, 46:907-911.
17. Weinshenker B.G., Bass B., Rice G.P., Noseworthy J., Carriere W., Baskerville J., et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989, 112:133-146.
18. Kremenchutzky M., Cottrell D., Rice G., Hader W., Baskerville J., Koopman W., et al. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain 1999, 122:1941-1950.
19. Miller D., Barkhof F., Montalban X., Thompson A., Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol 2005, 4:281-288.
20. Okuda D.T., Mowry E.M., Beheshtian A., Waubant E., Baranzini S.E., Goodin D.S., et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009, 72:800-805.
21. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707-717.
22. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 2007, 8:913-919.
23. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 2006, 354:942-955.
24. Ceccarelli A., Bakshi R., Neema M. MRI in multiple sclerosis: a review of the current literature. Curr Opin Neurol 2012, 25:402-409.
25. Schumacher G.A., Beebe G., Kibler R.F., Kurland L.T., Kurtzke J.F., McDowell F., et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965, 122:552-568.
26. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231.
27. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001, 50:121-127.
28. Barkhof F., Filippi M., Miller D.H., Scheltens P., Campi A., Polman C.H., et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997, 120:2059-2069.
29. Tintoré M., Rovira A., Martinez M.J., Rio J., Diaz-Villoslada P., Brieva L., et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000, 21:702-706.
30. Dalton C.M., Brex P.A., Miszkiel K.A., Hickman S.J., MacManus D.G., Plant G.T., et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002, 52:47-53.
31. Simon J.H., Li D., Traboulsee A., Coyle P.K., Arnold D.L., Barkhof F., et al. Standardized MR imaging protocol for multiple sclerosis: consortium of MS Centers consensus guidelines. AJNR Am J Neuroradiol 2006, 27:455-461.
32. Polman C.H., Reingold S.C., Edan C., Filippy M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005, 56:840-846.
33. Milo R., Miller A. Multiple Sclerosis. Diagnostic Criteria in Autoimune Diseases 2008, 401-406. Humana Press, [Chapter 73]. Y. Shoenfeld, R. Cervera, M.E. Gershwin (Eds.).
34. Swanton J.K., Fernando K., Dalton C.M., Miszkiel K.A., Thompson A.J., Plant G.T., et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006, 77:830-833.
35. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69:292-302.
36. Montalban X., Tintoré M., Swanton J., Barkhof F., Fazekas F., Filippi M., et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology 2010, 74:427-434.
37. Nielsen J.M., Uitdehaag B.M., Korteweg T., Barkhof F., Polman C.H. Performance of the Swanton multiple sclerosis criteria for dissemination in space. Mult Scler 2010, 16:985-987.
38. Díaz-Sánchez M., Mayra Gómez-Moreno S., Asunción Morales-Otal M., Ramos-González A., Benito-León J. Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes. Mult Scler 2010, 16:576-580.
39. Selchen D., Bhan V., Blevins G., Devonshire V., Duquette P., Grand'Maison F., et al. MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary. Neurology 2012, 79(Suppl. 2):S1-S15.
40. Sormani M.P., Tintorè M., Rovaris M., Rovira A., Vidal X., Bruzzi P., et al. Will Rogers phenomenon in multiple sclerosis. Ann Neurol 2008, 64:428-433.
41. Uitdehaag B.M.J., Barkhof F., Coyle P.K., Gardner J.D., Jeffery D.R., Mikol D.D. The changing face of multiple sclerosis clinical trial populations. Curr Med Res Opin 2011, 27:1529-1537.
42. Chard D.T., Dalton C.M., Swanton J., Fisniku L.K., Miszkiel K.A., Thompson A.J., et al. MRI only conversion to multiple sclerosis following a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 2011, 82:176-179.
43. Miller D.H., Weinshenker B.G., Filippi M., Banwell B.L., Cohen J.A., Freedman M.S., et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 2008, 14:1157-1174.
44. Liu S., Kullnat J., Bourdette D., Simon J., Kraemer D.F., Murchison C., et al. Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler 2013, 19:1101-1105.